Skip to content
Search:
Search
Facebook page opens in new window
 
ADCS
Alzheimer's Disease Cooperative Study
ADCSADCS
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • ADCS Steering Committee
    • Publications
  • Participate in Research
  • Public Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Types of Studies
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Intervention Selection Committee (ISC)
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Epstein Family Alzheimer’s Research Collaboration
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • ADCS Steering Committee
    • Publications
  • Participate in Research
  • Public Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Types of Studies
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Intervention Selection Committee (ISC)
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Epstein Family Alzheimer’s Research Collaboration

When a neuron gets blocked, the delicate harmony that allows the brain to operate seamlessly deteriorates. One result: diseases like Alzheimer’s. Understanding such blockages and how “traffic” should flow normally in healthy brain cells could offer hope to people with neurodegenerative diseases.

You are here:
  1. Home
  2. Research News
  3. When a neuron gets blocked,…

Toward that end, a research team led by University at Buffalo biologist Shermali Gunawardena, PhD, has shown that the protein presenilin plays an important role in controlling neuronal traffic on microtubule highways, a novel function that previously was unknown.

Post navigation

PreviousPrevious post:U.S. HHS released the National Plan to Address Alzheimer’s Disease: 2013 Update. The 2013 Update includes a new timeline for achieving its first goal – prevent and effectively treat Alzheimer’s disease by 2025 – and a review of progress over the past year.NextNext post:Additional data from the Phase III Gammaglobulin Alzheimer’s Partnership (GAP) study, including select analyses of subgroups, biomarker and imaging data, was presented at the Alzheimer’s Association International Conference (AAIC) in Boston, Massachusetts
ADCS Research News
  • Home Based Assessments Trial Primary Paper in the Journal of Alzheimer’s & Dementia
  • “Young Latino’s Working in Alzheimer’s” Airs Tonight on UCSD TV and is Streaming on the Brain Channel
  • 40 Sites Across The Country To Test New Alzheimer’s Drug
  • Newly discovered Alzheimer’s genes lead to hope for future treatments
  • ADCS Director Howard Feldman, MD talks about the T2 Protect trial and a bright future for Alzheimer’s research
Search
Find Us

Address
123 Main Street
New York, NY 10001

Hours
Monday—Friday: 9:00AM–5:00PM
Saturday & Sunday: 11:00AM–3:00PM

About ADCS
The Alzheimer’s Disease Cooperative Study (ADCS) was formed in 1991 as a cooperative agreement between the National Institute on Aging (NIA) and the University of California San Diego.
Contact Us
  • E-mail:
    adcsadmin@ucsd.edu
  • Phone:
    858-246-1333

Find us on:

Facebook page opens in new windowRss page opens in new windowMail page opens in new window
Location
Shipping Address:
9452 Medical Center Drive
4th Floor
La Jolla, CA 92037

Mailing Address:
9500 Gilman Dr
MC0949
La Jolla, CA 92093-0949
Copyright 2017 Regents of the University of California.
Go to Top